Healthcare provider profile · identity verified

Daniel James Whitmore, DO

Internal Medicine · HUNTINGTON, WV · NPI 1871573089

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	328	98
Amlodipine Besylate	Amlodipine Besylate	266	84
Losartan Potassium	Losartan Potassium	264	73
Atorvastatin Calcium	Atorvastatin Calcium	261	80
Lisinopril	Lisinopril	227	66
Levothyroxine Sodium	Levothyroxine Sodium	221	62
Potassium Chloride	Potassium Chloride	168	58
Albuterol Sulfate Hfa	Albuterol Sulfate	139	45
Furosemide	Furosemide	133	50
Montelukast Sodium	Montelukast Sodium	133	34
Metformin Hcl	Metformin Hcl	125	38
Tamsulosin Hcl	Tamsulosin Hcl	125	36
Fluticasone Propionate	Fluticasone Propionate	120	48
Gabapentin	Gabapentin	111	31
Metoprolol Succinate	Metoprolol Succinate	99	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	96	29
Rosuvastatin Calcium	Rosuvastatin Calcium	93	29
Citalopram Hbr	Citalopram Hydrobromide	88	24
Simvastatin	Simvastatin	88	28
Hydrochlorothiazide	Hydrochlorothiazide	83	24
Ozempic	Semaglutide	81	17
Carvedilol	Carvedilol	76	21
Allopurinol	Allopurinol	74	20
Amoxicillin	Amoxicillin	70	59
Ropinirole Hcl	Ropinirole Hcl	67	16
Trazodone Hcl	Trazodone Hcl	66	25
Prednisone	Prednisone	65	49
Clopidogrel	Clopidogrel Bisulfate	63	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	19
Doxycycline Hyclate	Doxycycline Hyclate	61	55
Ondansetron Hcl	Ondansetron Hcl	61	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	25
Januvia	Sitagliptin Phosphate	57	15
Meloxicam	Meloxicam	57	23
Sertraline Hcl	Sertraline Hcl	55	22
Tramadol Hcl	Tramadol Hcl	55	11
Jardiance	Empagliflozin	54	19
Metformin Hcl Er	Metformin Hcl	51	16
Famotidine	Famotidine	49	17
Atenolol	Atenolol	48	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	39
Hydroxyzine Hcl	Hydroxyzine Hcl	47	17
Metoprolol Tartrate	Metoprolol Tartrate	46	14
Arexvy	Rsvpref3 Antigen/As01e/Pf	45	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	18
Chlorthalidone	Chlorthalidone	42	14
Nifedipine Er	Nifedipine	42	12
Glipizide	Glipizide	41	suppressed
Ibuprofen	Ibuprofen	41	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	12
Azithromycin	Azithromycin	40	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	25
Fluconazole	Fluconazole	37	24
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	12
Lovastatin	Lovastatin	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Novolog Flexpen	Insulin Aspart	34	13
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Mupirocin	Mupirocin	33	26
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	33	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Meclizine Hcl	Meclizine Hcl	29	16
Duloxetine Hcl	Duloxetine Hcl	28	11
Methocarbamol	Methocarbamol	28	16
Nystatin	Nystatin	28	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	21
Esomeprazole Magnesium	Esomeprazole Magnesium	27	11
Gemfibrozil	Gemfibrozil	27	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Cephalexin	Cephalexin	21	18
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Finasteride	Finasteride	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Eliquis	Apixaban	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	18
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Invokana	Canagliflozin	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Atrovent Hfa	Ipratropium Bromide	14	suppressed
Diazepam	Diazepam	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Clonazepam	Clonazepam	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error